Moderna

News

BioNTech bites back after CureVac patent challenge

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will "vigorously" defend itself.

News

US panel backs Omicron-targeting vaccines for booster campai...

Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according to the FDA's Vaccines and Related Biological Produc

News

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

Moderna says COVID booster works against Omicron subvariants

Moderna has reported top-line data suggesting that its COVID-19 booster vaccine candidate stimulates a strong immune response against the Omicron subvariants BA.4 and BA.5, which have drive

News

Moderna facility in UK confirmed, part of 10-year deal with ...

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments.

News

FDA advisors back COVID jabs for very young children

The FDA's vaccines advisors have voted in favour of extending the use of mRNA-based COVID-19 vaccine from Moderna and Pfizer/BioNTech to include children from the ages of six months.

News

Relief for GSK as RSV vaccine clears phase 3 test in adults

GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV) vaccine straight away, after the shot hit the mark in the much-anticipated AReSVi 006 trial in ad

BioNTech bites back after CureVac patent challenge

US panel backs Omicron-targeting vaccines for booster campai...

Moderna says COVID booster works against Omicron subvariants

Moderna facility in UK confirmed, part of 10-year deal with ...

FDA advisors back COVID jabs for very young children

Relief for GSK as RSV vaccine clears phase 3 test in adults

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Moderna

Editor's Picks